2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$52.98-$0.21 (-0.39%)
Price as of Jun 23, 2026 6:44 PM EDT- $4.2BMarket Cap
- 99.14%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$52.98-$0.21 (-0.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 493.2M +10.63% | 445.8M +23.46% | 361.1M +21.76% | 296.5M +35.09% | |
Cost of Revenue | 127.6M -53.13% | 272.1M +141.03% | 112.9M +11.14% | 101.6M +36.53% | |
Gross Profit | 362.5M +21.60% | 298.1M +20.15% | 248.1M +27.29% | 195.0M +34.35% | |
Sales and Marketing Expense | 100.2M +4.96% | 95.4M -5.97% | 101.5M +4.03% | 97.6M +22.19% | |
Research and Development Expense | -70.8M +2.19% | -69.3M +20.92% | -57.3M +41.13% | -40.6M +36.06% | |
Depreciation and Amortization Expense | 21.4M -8.71% | 23.5M -13.72% | 27.2M +4.86% | 25.9M +32.33% | |
Total Operating Expenses | 2.5M -62.28% | 6.6M -98.52% | 446.8M +32.35% | 337.6M +12.01% | |
Operating Profit | 57.8M +257.93% | 16.1M +118.81% | -85.8M +108.84% | -41.1M -49.84% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 10.4M +8.56% | 9.6M +4.56% | 9.2M +97.31% | 4.7M +1,732.28% | |
Income before Taxes | 68.2M +164.92% | 25.7M +133.60% | -76.6M +110.32% | -36.4M -55.39% | |
Income Taxes | 1.8M +15.07% | 1.6M +172.74% | -2.2M -1,760.15% | 133,000 +102.19% | |
Extraordinary Items | 20.5M +508.82% | 3.4M -95.07% | 68.3M N/A | N/A N/A | |
Net Income | 66.4M +174.89% | 24.1M +132.44% | -74.4M +103.51% | -36.6M -51.62% | |
Net Income from Continuing Operations Applicable to Common | 68.2M +164.92% | 25.7M +133.60% | -76.6M +110.32% | -36.4M -55.39% | |
Basic EPS and Net Income | 0.84 +162.50% | 0.32 +131.37% | -1.02 +100.00% | -0.51 -54.05% | |
Diluted EPS and Net Income | 0.82 +164.52% | 0.31 +130.39% | -1.02 +100.00% | -0.51 -54.05% | |
Basic Weighted Average Shares | 78.6M +2.75% | 76.5M +5.29% | 72.6M +1.53% | 71.5M +5.39% | |
Diluted Weighted Average Shares | 80.6M +3.08% | 78.2M +7.60% | 72.6M +1.53% | 71.5M +5.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 362.6M +51.65% | 239.1M +10.46% | 216.5M +40.33% | 154.2M -10.94% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 362.6M +51.65% | 239.1M +10.46% | 216.5M +40.33% | 154.2M -10.94% | |
Total Current Assets | 488.4M +31.19% | 372.3M +30.34% | 285.6M +14.88% | 248.6M +2.28% | |
Accumulated Depreciation | 43.5M +10.39% | 39.4M +19.87% | 32.9M +26.47% | 26.0M +20.95% | |
Property and Plant and Equipment and Net | 22.2M -3.32% | 23.0M +11.51% | 20.6M +16.28% | 17.7M +17.25% | |
Total Long-Term Assets | 902,000 -87.08% | 7.0M +16.92% | 6.0M +10.21% | 5.4M +146.50% | |
Total Assets | 1.4B +8.15% | 1.3B +16.60% | 1.1B -3.59% | 1.2B -2.64% | |
Income Taxes Payable | 646,000 -47.35% | 1.2M +67.17% | 734,000 -83.80% | 4.5M -18.97% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 59.9M -23.78% | 78.6M +28.40% | 61.2M -2.19% | 62.6M -2.40% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 1 N/A | |
Total Long-Term Liabilities | 0 -100.00% | 411,000 -47.71% | 786,000 -15.57% | 931,000 -33.83% | |
Total Liabilities | 96.4M -22.27% | 124.1M +75.23% | 70.8M -12.83% | 81.2M -11.05% | |
Retained Earnings | -377.6M -14.94% | -444.0M -5.16% | -468.1M +18.90% | -393.7M +10.24% | |
Total Stockholders Equity | 1.3B +11.36% | 1.2B +12.63% | 1.0B -2.89% | 1.1B -1.94% | |
Total Shares Outstanding | 79.4M +2.04% | 77.8M +6.15% | 73.3M +1.81% | 72.0M +1.18% | |
Cash Flow | |||||
Cash from Operating Activities | 136.3M +81.51% | 75.1M +69.82% | 44.2M +486.89% | 7.5M +123.83% | |
Capital Expenditures | 9.7M -14.26% | 11.3M +13.31% | 10.0M +16.52% | 8.5M +59.02% | |
Cash from Investing Activities | -9.2M -83.64% | -56.3M -472.39% | 15.1M +151.42% | -29.4M -96.02% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.2M -186.09% | 4.9M +72.86% | 2.8M -18.80% | 3.5M -99.41% | |
Financials Ratio | |||||
Gross Margin | 74.13% +90.32% | 38.95% -43.33% | 68.73% +4.54% | 65.74% -0.55% | |
Operating Margin | 11.72% +223.53% | 3.62% +115.24% | -23.76% +71.53% | -13.85% -62.87% | |
Return on Assets | 4.90% +145.31% | 2.00% +130.51% | -6.55% +110.05% | -3.12% -66.05% | |
Return on Equity | 5.34% +145.53% | 2.17% +130.97% | -7.02% +108.55% | -3.37% -66.19% | |
Revenue Growth | 10.63% -54.69% | 23.46% +7.84% | 21.76% -37.99% | 35.09% -59.60% | |
Current Ratio | 8.15 +72.11% | 4.73 +1.51% | 4.66 +17.45% | 3.97 +4.79% | |
Cash Ratio | 6.05 +98.96% | 3.04 -13.98% | 3.53 +43.47% | 2.46 -8.75% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.00 -100.00% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.00 -100.00% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow